Drug intelligence / Profile preview

sodium lactate + calcium chloride + sodium chloride + magnesium chloride + dextrose

Development stage
Approved
Lead developer
Takeda
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

A sterile **peritoneal dialysis solution** containing **dextrose, sodium lactate, sodium chloride, calcium chloride, and magnesium chloride**, developed and marketed by **Baxter Healthcare** for intraperitoneal use in patients with renal failure. In this combination, **dextrose acts as the osmotic agent** that drives ultrafiltration across the peritoneal membrane, enabling removal of excess water and uremic solutes, while **sodium lactate serves as the buffer precursor** and the electrolytes help maintain physiologic ionic composition during dialysis. This product family is marketed under brands including **DELFLEX** and **DIANEAL** formulations and is indicated for **chronic kidney failure** in peritoneal dialysis patients and, for certain DIANEAL products, **acute or chronic renal failure**.

Brand names
DELFLEXDIANEAL Low CalciumDIANEAL PD-2
Other names
dextrose monohydrate + sodium chloride + sodium lactate + calcium chloride + magnesium chlorideperitoneal dialysis solution

Beyond the preview

Go deeper on sodium lactate + calcium chloride + sodium chloride + magnesium chloride + dextrose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium lactate + calcium chloride + sodium chloride + magnesium chloride + dextrose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call